$JUNS Up 31% Premarket! 🚀 🔹 Big move as traders react to a $100M term sheet for exclusive U.S. rights to ALA-002, a next-gen MDMA therapeutic 🧠 🔹 Jupiter Ne

$JUNS Up 31% Premarket! 🚀 🔹 Big move as traders react to a $100M term sheet for exclusive U.S. rights to ALA-002, a next-gen MDMA therapeutic 🧠 🔹 Jupiter Neurosciences is a clinical-stage biotech focused on CNS disorders and neuroinflammation 🧬 🔹 Company also announced a $2M registered direct …